# Rosa canina Extract Attenuates Muscle Atrophy in L6 Myotubes and Immobilized Mice

**Authors:** Hyerin Lee, Mi-Bo Kim, Junhui Kang, Jae-Kwan Hwang, Bohkyung Kim

PMC · DOI: 10.3390/nu17213462 · Nutrients · 2025-11-02

## TL;DR

Rosa canina extract reduces muscle atrophy in lab and animal models by reducing inflammation and oxidative stress and promoting muscle growth.

## Contribution

This study is the first to demonstrate Rosa canina extract's protective effects against muscle atrophy through multiple molecular mechanisms in both in vitro and in vivo models.

## Key findings

- RCE reduced inflammation and oxidative stress while preserving myogenic markers in L6 myotubes.
- RCE inhibited muscle proteolysis and activated the PI3K/Akt/mTOR pathway to promote protein synthesis.
- In mice, RCE preserved muscle mass, fiber size, and strength in an immobilization model of atrophy.

## Abstract

Background: Skeletal muscle is essential not only for structural integrity but also metabolic homeostasis. Muscle atrophy, the loss of muscle mass and function, is closely linked to chronic and metabolic disorders and is driven by chronic inflammation, oxidative stress, impaired myogenesis, and disrupted protein homeostasis. The present study aimed to evaluate the protective effects and underlying mechanisms of Rosa canina extract (RCE), a polyphenol-rich plant known for its antioxidant and anti-inflammatory properties, in vitro and in vivo models of muscle atrophy. Methods: We investigated the effects of RCE in TNF-α-treated L6 myotubes and a mouse model (eight-week-old male C57BL/6N) of immobilization-induced muscle atrophy. Markers of inflammation, oxidative stress, myogenesis, protein turnover, and anabolic signaling were analyzed via RT-PCR, Western blotting and ELISA. Muscle mass, performance, micro-CT imaging, and histological cross-sectional area were assessed in vivo. Results: RCE suppressed pro-inflammatory cytokines, restored antioxidant enzyme expression, and preserved myogenic markers. It inhibited muscle proteolysis by downregulating the genes involved in protein degradation and promoted protein synthesis by via activation of the PI3K/Akt/mTOR pathway. In mice, RCE mitigated muscle mass loss, preserved fiber cross-sectional area, improved strength and endurance, and restored muscle volume. Conclusions: RCE attenuated muscle atrophy by targeting inflammation, oxidative stress, proteolysis, and impaired anabolism. These findings highlight RCE as a promising natural therapeutic for preserving muscle health and metabolic homeostasis.

## Linked entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}
- **Diseases:** loss of muscle mass and function (MESH:D009135), inflammation (MESH:D007249), Muscle Atrophy (MESH:D009133), metabolic disorders (MESH:D008659), muscle mass loss (MESH:C536030)
- **Chemicals:** RCE (-), polyphenol (MESH:D059808)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12608495/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12608495/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12608495/full.md

---
Source: https://tomesphere.com/paper/PMC12608495